БАЧАДОН БЎЙНИ ФОН, ПРЕКАНЦЕРОЗ ВА НЕОПЛАСТИК ЖАРАЁНЛАРИНИНГ ГИСТОМОРФОЛОГИК ХУСУСИЯТЛАРИ: БИОПСИЯ МАТЕРИАЛЛАРИ АСОСИДА РЕТРОСПЕКТИВ ТАҲЛИЛ
Abstract
Долзарблиги. Бачадон бўйнининг фон, преканцероз ва неопластик жараёнлари аёллар репродуктив тизими патологиясида муҳим ўрин тутади. Бачадон бўйни эпителийсидаги яллиғланиш, регенератор-метапластик ва HPV билан боғлиқ ўзгаришларни ўз вақтида морфологик аниқлаш преканцероз жараёнларни инвазив ўсмага ўтишидан олдин ташхислаш имконини беради.
References
1. WHO Classification of Tumours Editorial Board. Female Genital Tumours. WHO Classification of Tumours. 5th ed. Vol. 4. Lyon: International Agency for Research on Cancer; 2020.
2. World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. Second edition. Geneva: WHO; 2021.
3. World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of mRNA tests for human papillomavirus (HPV). Geneva: WHO; 2021.
4. International Agency for Research on Cancer. Cervical Cancer Screening. IARC Handbooks of Cancer Prevention, Volume 18. Lyon: IARC; 2022.
5. Darragh T.M., Colgan T.J., Cox J.T., et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated lesions: background and consensus recommendations. Archives of Pathology & Laboratory Medicine. 2012;136(10):1266–1297.
6. Stoler M.H., Bergeron C., Colgan T.J., et al. Squamous cell tumours and precursors. In: WHO Classification of Tumours Editorial Board. Female Genital Tumours. 5th ed. Lyon: IARC; 2020.
7. Schiffman M., Doorbar J., Wentzensen N., et al. Carcinogenic human papillomavirus infection. Nature Reviews Disease Primers. 2016;2:16086.
8. Crosbie E.J., Einstein M.H., Franceschi S., Kitchener H.C. Human papillomavirus and cervical cancer. The Lancet. 2013;382(9895):889–899.
9. Wentzensen N., Clarke M.A. Cervical cancer screening—past, present, and future. Cancer Epidemiology, Biomarkers & Prevention. 2022;31:432–434.
10. World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: WHO; 2020.
11. World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of dual-stain cytology to triage women after a positive HPV test. Geneva: WHO; 2024.
12. World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of human papillomavirus (HPV) DNA genotyping. Geneva: WHO; 2026.
